<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><strong><u>REACTIVE ERETHYMA AND BOLLUS REACTION</u></strong></p><p>These are immunologic reactions characterized by reddening with or without blistering of the skin and/or mucosa. The common types are erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN). With all these conditions, there could be accompanying extensive denudation of skin with consequent fluid and electrolyte loss and a risk of secondary bacterial infection. All three conditions should be considered as emergencies requiring intensive care.</p><p>Erythema multiforme presents as itchy, target-like, non-scaly lesions of the palms, soles, forearms and legs.</p><p>Stevens-Johnson syndrome is characterized by erythema and blister formation, which additionally involves the mucous membranes (conjunctiva, mouth, genitals etc.).</p><p>Toxic epidermal necrolysis (TEN) is a generalized scalded type of skin reaction, often due to an allergic reaction to drugs. A similar reaction occurs in children termed staphylococcal scalded skin syndrome, which is caused by <i>Staphylococcus aureus</i>.</p><p> </p><p><strong>CAUSES</strong></p><ul><li>Viral infections e.g. herpes simplex virus, retrovirus, cytomegalovirus</li><li>Mycoplasma pnuemoniae infection</li><li>Adverse drug reaction e.g. to sulphonamides, penicillin, NSAIDS, anticonvulsants etc.</li><li>Malignancy</li></ul><p> </p><p><strong>SYMPTOMS</strong></p><ul><li>Fever</li><li>Blisters</li><li>Itchy rash</li><li>Sore throat</li><li>General malaise</li><li>Discharging painful eyes</li><li>Asymptomatic</li></ul><p> </p><p><strong>SIGNS</strong></p><ul><li>Fever</li><li>Flaccid bullae</li><li>Genital and/or oral ulcerations</li><li>Denuded area of skin</li></ul><p> </p><p> </p><p><strong>INVESTIGATIONS</strong></p><ul><li>FBC</li><li>BUE &amp; creatinine</li><li>HIV screen</li><li>Blood and wound cultures (if indicated)</li></ul><p> </p><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To maintain adequate hydration</li><li>To maintain adequate nutrition</li><li>To correct electrolyte imbalance</li><li>To maintain normal body temperature</li><li>To prevent secondary infection</li><li>To identify and eliminate underlying cause</li><li>To prevent further exposure to the causative agent or drug</li></ul><p> </p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Withdrawal of identifiable causative agent or drug</li><li>Maintenance of adequate input and output of fluid</li><li>Adequate oral fluids</li><li>Prevent contact of ulcerated skin with contaminated linen using a nursing cradle</li><li>Early ophthalmological consultation</li><li>Nutritious diet</li></ul><p> </p><p><strong>Pharmacological treatment</strong></p><p><strong>A. For adequate rehydration</strong></p><ul><li>Normal saline, IV,</li></ul><p> </p><p><strong>B. For Pain and Fever</strong></p><p>Evidence Rating: [A]</p><ul><li>Paracetamol, oral,<ol><li>years;  120-250 mg 6-8 hourly</li></ol></li></ul><p><strong><u>Adults</u></strong></p><p>500 mg-1 g 6-8 hourly</p><p><strong><u> </u></strong></p><p><strong><u>Children</u></strong></p><p>6-12 years; 250-500 mg 6-8 hourly</p><p>3    months-1 year;  60-120 mg 6-8 hourly</p><p> </p><p><strong>C. For Control of the Immune Process in patients who can swallow</strong></p><p>Evidence Rating: [C]</p><ul><li>Prednisolone, oral, (at onset of condition)<ol><li>mg/kg daily and taper off over 7-10 days</li></ol></li></ul><p><strong><u>Adults</u></strong></p><p>0.5-1 mg/kg daily and taper off over 7-10 days</p><p><strong><u>Children</u></strong></p><p> </p><p><strong>D. For Control of the Immune Process in patients who cannot</strong></p><p><strong>swallow</strong></p><ul><li>Hydrocortisone, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>100 mg 6 hourly until able to swallow</p><p><strong>Then</strong></p><ul><li>Prednisolone, oral, as above</li></ul><p><strong><u>Children</u></strong></p><p>4 mg/kg 6 hourly until able to swallow</p><p><strong>Then</strong></p><ul><li>Prednisolone, oral, as above</li></ul><p><strong>E. To treat Secondary Bacterial Skin Infection or Mycoplasma</strong></p><p><strong>Pneumonia</strong></p><p>Evidence Rating: [B]</p><ul><li>Azithromycin, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg daily for 5 days</p><p><strong><u>Children</u></strong></p><p>10 mg/kg once daily for 5 days</p><p>&lt; 6 months;  not recommended 0r</p><ul><li>Erythromycin, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 6 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>6-12 years; 250 mg 6 hourly for 7 days</p><p>1-5 years;  125 mg 6 hourly for 7 days</p><p>&lt; 1 year; 62.5 mg 6 hourly for 7 days</p><p> </p><p><strong>F. For prevention of skin infections</strong></p><p>Evidence Rating: [C]</p><ul><li>Chlorhexidine solution 4%, topical,</li></ul><p><strong>Or</strong></p><ul><li>Cetrimide 15%, topical,</li></ul><p><strong>Or</strong></p><ul><li><br>Povidone iodine solution 10%, topical, </li></ul><p> </p><p> </p><p><strong>G. For oral ulcers</strong></p><ul><li>Povidone iodine 1% mouthwash, 12 hourly</li></ul><p><strong>Or</strong></p><ul><li>Chlorhexidine 0.12% mouthwash, 12 hourly</li></ul><p> </p><p> </p><p><strong>REFERRAL CRITERIA</strong></p><p>Refer all patients to appropriate specialist.</p><p> </p>
</body>
</html>
